Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy

Saved in:
Bibliographic Details
Published inAIDS (London) Vol. 17; no. 5; pp. 784 - 786
Main Authors MAZERON, Marie-Christine, FILLET, Anne-Marie, SCIEUX, Catherine, IMBERT, Berthe-Marie, DENY, Paul, BOUR, Jean-Baptiste, FREYMUTH, Francois, CHANZY, Bruno, CHAPUT, Sophie, COSTAGLIOLA, Dominique, SALMON, Dominique, BOUKLI, Narjis, HOUHOU, Nadira, SENECHAL, Brigitte, MATHERON, Sophie, GOZLAN, Joël, LEPORT, Catherine, KATLAMA, Christine
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 28.03.2003
Subjects
AIDS-Related Opportunistic Infections - diagnosis
AIDS/HIV
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiretroviral Therapy, Highly Active
Antiviral agents
Biological and medical sciences
Biomarkers - blood
Cytomegalovirus Infections - diagnosis
HIV Infections - drug therapy
Human viral diseases
Humans
Infectious diseases
Medical sciences
Pharmacology. Drug treatments
Prospective Studies
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Human
Immunopathology
Herpesviridae
Biological marker
AIDS
Betaherpesvirinae
Immune deficiency
Human cytomegalovirus
Infection
Virus
Chemotherapy
Treatment
Viral disease
Antiviral
Viral load
Quantitative analysis
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0269-9370
1473-5571
DOI:10.1097/00002030-200303280-00029